Albert B. Sabin Vaccine Institute
Clinical trials sponsored by Albert B. Sabin Vaccine Institute, explained in plain language.
-
New marburg vaccine trial aims to protect against deadly virus
⭐️ VACCINE ⭐️ OngoingThis study tests an experimental vaccine against Marburg virus, a rare but severe disease. About 200 healthy adults will receive either the vaccine or a placebo to check for side effects and measure immune responses. The goal is to see if the vaccine is safe and prompts the body …
Phase: PHASE2 • Sponsor: Albert B. Sabin Vaccine Institute • Aim: ⭐️ VACCINE ⭐️
Last updated May 25, 2026 12:23 UTC
-
New sudan ebola vaccine moves to phase 2 testing
⭐️ VACCINE ⭐️ OngoingThis study tests a new vaccine against Sudan Ebola virus in 200 healthy adults aged 18 to 70. The vaccine uses a harmless chimpanzee virus to deliver protection. Researchers will check for side effects and measure immune responses to see if the vaccine is safe and works.
Phase: PHASE2 • Sponsor: Albert B. Sabin Vaccine Institute • Aim: ⭐️ VACCINE ⭐️
Last updated May 19, 2026 11:46 UTC